This article is more than 5 years old. Information may no longer be current.
VIDEO: Deepak L. Bhatt, MD, MPH, highlights top takeaways from ACC
Click Here to Manage Email Alerts
ORLANDO, Fla. —In this video exclusive, Cardiology Today’s Intervention Chief Medical Editor Deepak L. Bhatt, MD, MPH, provides his take on four trials presented at the American College of Cardiology Scientific Session.
Bhatt, executive director of interventional cardiovascular programs at Brigham and Women’s Heart & Vascular Center and professor of medicine at Harvard Medical School, says “there will be a lot of discussion” about results of the ODYSSEY Outcomes trial of alirocumab (Praluent, Sanofi/Regeneron) in patients with ACS on statin therapy.
Bhatt is also “interested to see how the medical community reacts to” results of the VEST trial of a lightweight wearable vest equipped with a cardioverter defibrillator and the impact on mortality in post-MI patients with reduced ejection fraction.
New 5-year data from NOTION, which looked at transcatheter vs. surgical aortic valve replacement in patients with severe aortic valve stenosis, and COMPASS, which looked at mortality after major adverse limb events in peripheral artery disease, are also of interest and bring new questions to the forefront for cardiologists and interventional cardiologists.